Association Between Chinese Visceral Adipose Index and Albuminuria in Chinese Adults: A Cross-Sectional Study

References

• Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017;2(2):e000380. doi:10.1136/bmjgh-2017-000380
   PubMed Web of Science ®Google Scholar
• Dobrowolski P, Januszewicz A, Gumprecht J, et al. Why albuminuria should be assessed more frequently in everyday clinical practice? A position statement. Pol Arch Intern Med. 2021;131(4):396–406. doi:10.20452/pamw.15874
   PubMedGoogle Scholar
• Ohkuma T, Jun M, Chalmers J, et al. Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes. Clin J Am Soc Nephrol. 2019;14(6):862–872. doi:10.2215/CJN.13391118
   PubMed Web of Science ®Google Scholar
• Lees JS, Welsh CE, Celis-Morales CA, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019;25(11):1753–1760. doi:10.1038/s41591-019-0627-8
   PubMed Web of Science ®Google Scholar
• Kühn A, van der Giet M, Kuhlmann MK, et al. Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults. Am J Kidney Dis. 2021;77(3):386–396.e1. doi:10.1053/j.ajkd.2020.09.015
   PubMed Web of Science ®Google Scholar
• Xie X, Peng Z, Li H, et al. Association of urine albumin/creatinine ratio below 30 mg/g and left ventricular hypertrophy in patients with type 2 diabetes. Biomed Res Int. 2020;2020:5240153. doi:10.1155/2020/5240153
   PubMed Web of Science ®Google Scholar
• Zhang A, Li M, Qiu J, et al. The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: a 10-year follow-up study. BMC Nephrol. 2022;23(1):16. doi:10.1186/s12882-021-02644-z
   PubMed Web of Science ®Google Scholar
• Coresh J, Heerspink HJL, Sang Y, et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019;7(2):115–127. doi:10.1016/S2213-8587(18)30313-9
   PubMed Web of Science ®Google Scholar
• Martin WP, Bauer J, Coleman J, et al. Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centre. Clin Obes. 2020;10(6):e12402. doi:10.1111/cob.12402
   PubMed Web of Science ®Google Scholar
• Qin S, Wang A, Gu S, et al. Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study. BMJ Open. 2021;11(1):e040214. doi:10.1136/bmjopen-2020-040214
   PubMed Web of Science ®Google Scholar
• Xu X, Eales JM, Jiang X, et al. Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics. Cardiovasc Res. 2022;118(15):3151–3161. doi:10.1093/cvr/cvab357
   PubMed Web of Science ®Google Scholar
• Xia MF, Chen Y, Lin HD, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214. doi:10.1038/srep38214
   PubMed Web of Science ®Google Scholar
• Bi H, Zhang Y, Qin P, et al. Association of Chinese visceral adiposity index and its dynamic change with risk of carotid plaque in a large cohort in China. J Am Heart Assoc. 2022;11(1):e022633. doi:10.1161/JAHA.121.022633
   PubMed Web of Science ®Google Scholar
• Sánchez-íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197. doi:10.1111/eci.12583
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi:10.1681/ASN.2006040368
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society. Guidelines for the prevention and treatment of type 2 diabetes in China (2020 edition). Chin J Diabetes. 2021;13(4):315–409.
   Google Scholar
• Wang F, He K, Wang J, et al. Prevalence and risk factors for CKD: a comparison between the adult populations in China and the United States. Kidney Int Rep. 2018;3(5):1135–1143. doi:10.1016/j.ekir.2018.05.011
   PubMed Web of Science ®Google Scholar
• Lin CA, Liu YP, Chen YC, et al. Gender-specific and age-specific associations of the homoeostasis model assessment for IR (HOMA-IR) with albuminuria and renal function impairment: a retrospective cross-sectional study in Southeast China. BMJ Open. 2021;11(12):e053649. doi:10.1136/bmjopen-2021-053649
   PubMed Web of Science ®Google Scholar
• Cao Y, Sun G, Liu R, et al. Plasma triglyceride levels and central obesity predict the development of kidney injury in Chinese community older adults. Ren Fail. 2019;41(1):946–953. doi:10.1080/0886022X.2019.1655451
   PubMed Web of Science ®Google Scholar
• Polkinghorne KR, Wolfe R, Jachno KM, et al. Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly study cohort. Nephrology. 2019;24(12):1248–1256. doi:10.1111/nep.13565
   PubMed Web of Science ®Google Scholar
• Duan JY, Duan GC, Wang CJ, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 2020;21(1):115. doi:10.1186/s12882-020-01761-5
   PubMed Web of Science ®Google Scholar
• Duan J, Wang C, Liu D, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. 2019;9(1):10408. doi:10.1038/s41598-019-46857-7
   PubMed Web of Science ®Google Scholar
• Ji A, Pan C, Wang H, et al. Prevalence and associated risk factors of chronic kidney disease in an elderly population from Eastern China. Int J Environ Res Public Health. 2019;16(22):4383. doi:10.3390/ijerph16224383
   PubMed Web of Science ®Google Scholar
• Rosenstock JL, Pommier M, Stoffels G, Patel S, Michelis MF. Prevalence of proteinuria and albuminuria in an obese population and associated risk factors. Front Med. 2018;5:122. doi:10.3389/fmed.2018.00122
   Web of Science ®Google Scholar
• Hughes JT, Maple-Brown LJ, Thomas M, et al. Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study. Nephrology. 2018;23(1):37–45. doi:10.1111/nep.12956
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein M, Weinstein T, Chagnac A. Obesity-related glomerulopathy: clinical management. Semin Nephrol. 2021;41(4):358–370. doi:10.1016/j.semnephrol.2021.06.007
   PubMed Web of Science ®Google Scholar
• Wang J, Niratharakumar K, Gokhale K, et al. Obesity without metabolic abnormality and incident CKD: a population-based British cohort study. Am J Kidney Dis. 2022;79(1):24–35.e1. doi:10.1053/j.ajkd.2021.05.008
   PubMed Web of Science ®Google Scholar
• Choi I, Moon H, Kang SY, Ko H, Shin J, Lee J. The risk of microalbuminuria by obesity phenotypes according to metabolic health and obesity: the Korean National Health And Nutrition Examination Survey 2011–2014. Korean J Fam Med. 2018;39(3):168–173. doi:10.4082/kjfm.2018.39.3.168
   PubMed Web of Science ®Google Scholar
• Tsuda A, Ishimura E, Uedono H, et al. Association of albuminuria with intraglomerular hydrostatic pressure and insulin resistance in subjects with impaired fasting glucose and/or impaired glucose tolerance. Diabetes Care. 2018;41(11):2414–2420. doi:10.2337/dc18-0718
   PubMed Web of Science ®Google Scholar
• Hadi Alijanvand M, Aminorroaya A, Kazemi I, et al. Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study. Diabetes Metab Syndr Obes. 2019;12:1123–1139. doi:10.2147/DMSO.S189726
   PubMed Web of Science ®Google Scholar
• Castro BBA, Foresto-Neto O, Saraiva-Camara NO, Sanders-Pinheiro H. Renal lipotoxicity: insights from experimental models. Clin Exp Pharmacol Physiol. 2021;48(12):1579–1588. doi:10.1111/1440-1681.13556
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118. doi:10.1186/s12933-020-01095-4
   PubMed Web of Science ®Google Scholar
• Wu Z, Yu S, Kang X, et al. Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population. Cardiovasc Diabetol. 2022;21(1):32. doi:10.1186/s12933-022-01464-1
   PubMed Web of Science ®Google Scholar
• Wan EYF, Eyt Y, Chin WY, et al. Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study. Sci Rep. 2021;11(1):8047. doi:10.1038/s41598-021-87067-4
   PubMed Web of Science ®Google Scholar
• Hsu W-H, Lai C-W, Chen S-C, et al. Greater low-density lipoprotein cholesterol variability increases the risk of cardiovascular events in patients with type 2 diabetes mellitus. Endocr Pract. 2019;25(9):918–925. doi:10.4158/EP-2019-0002
   PubMed Web of Science ®Google Scholar
• Sun X, Liu J, Wang G. Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia. Lipids Health Dis. 2020;19(1):103. doi:10.1186/s12944-020-01254-2
   PubMed Web of Science ®Google Scholar
• Kataoka-Yahiro M, Davis J, Gandhi K, Rhee CM, Page V. Asian Americans & chronic kidney disease in a nationally representative cohort. BMC Nephrol. 2019;20(1):10. doi:10.1186/s12882-018-1145-5
   PubMedGoogle Scholar
• Choi AI, Karter AJ, Liu JY, Young BA, Go AS, Schillinger D. Ethnic differences in the development of albuminuria: the DISTANCE study. Am J Manag Care. 2011;17(11):737–745.
   PubMed Web of Science ®Google Scholar
• Peralta CA, Bibbins-Domingo K, Vittinghoff E, et al. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27(3):887–893. doi:10.1681/ASN.2015020124
   PubMed Web of Science ®Google Scholar
• Teumer A, Li Y, Ghasemi S, et al. Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat Commun. 2019;10(1):4130. doi:10.1038/s41467-019-11576-0
   PubMedGoogle Scholar
• Paluch AE, Pool LR, Isakova T, et al. Association of fitness with racial differences in chronic kidney disease. Am J Prev Med. 2019;57(1):68–76. doi:10.1016/j.amepre.2019.02.016
   PubMed Web of Science ®Google Scholar
• Liang Z, Wang L, Liu H, et al. Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes. Clin Nutr. 2020;39(7):2144–2150. doi:10.1016/j.clnu.2019.08.032
   PubMed Web of Science ®Google Scholar